Which company developed India's first indigenous dengue vaccine, "DengiAll," currently in Phase 3 trials?

A)
Zydus Cadila
B)
Bharat Biotech
C)
Panacea Biotec
D)
Serum Institute of India

Correct Answer :   Panacea Biotec


Panacea Biotec developed DengiAll, India's first indigenous dengue vaccine, which is currently in Phase 3 trials.

The vaccine targets all four dengue virus serotypes and is being tested across 19 sites with over 10,000 participants.

This development is crucial as dengue remains a significant public health challenge in India, transmitted by Aedes mosquitoes.

The successful trial of DengiAll could provide a vital tool in combating this widespread disease.

Published On : August 14, 2024